Traditional influenza diagnostic Market - Global Outlook and Forecast 2023-2028

Report ID: 1567475 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story

Traditional influenza diagnostic is mainly rapid influenza detection test. Commercial rapid influenza diagnostic tests are available that can detect influenza viruses within 20 minutes.
This report contains market size and forecasts of Traditional influenza diagnostic in Global, including the following market information:
Global Traditional influenza diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Traditional influenza diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid Influenza Detection Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Traditional influenza diagnostic include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Traditional influenza diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Traditional influenza diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Traditional influenza diagnostic Market Segment Percentages, by Type, 2021 (%)
Rapid Influenza Detection Tests
Viral Culture
Direct Fluorescent Antibody (DFA) Tests
Serological Assays
Global Traditional influenza diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Traditional influenza diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
POCT
Others
Global Traditional influenza diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Traditional influenza diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Traditional influenza diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Traditional influenza diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

Frequently Asked Questions
Traditional influenza diagnostic Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Traditional influenza diagnostic Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Traditional influenza diagnostic Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports